Douglas L Feinstein Selected Research

bromfenacoum (Ratak)

1/2021	Brodifacoum pharmacokinetics in acute human poisoning: implications for estimating duration of vitamin K therapy.
6/2020	Separation and Quantification of Superwarfarin Rodenticide Diastereomers-Bromadiolone, Difenacoum, Flocoumafen, Brodifacoum, and Difethialone-in Human Plasma.
1/2020	Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.
5/2019	The relative toxicity of brodifacoum enantiomers.
3/2019	Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?
10/2018	The Bile Sequestrant Cholestyramine Increases Survival in a Rabbit Model of Brodifacoum Poisoning.
2/2017	Brodifacoum poisoning: A clear and present danger to public health in the USA.
1/2017	The Long-Lasting Rodenticide Brodifacoum Induces Neuropathology in Adult Male Rats.
1/2016	The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasures.
1/2016	Membrane Cholesterol Modulates Superwarfarin Toxicity.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas L Feinstein Research Topics

Disease

25	Multiple Sclerosis 10/2023 - 03/2004
17	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022 - 02/2002
16	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 04/2002
13	Poisoning 04/2024 - 01/2015
9	Glioma (Gliomas) 10/2019 - 08/2002
9	Disease Progression 01/2017 - 07/2002
9	Inflammation (Inflammations) 01/2017 - 04/2002
6	Cardiotoxicity 05/2015 - 05/2003
5	Hemorrhage 04/2024 - 01/2019
5	Demyelinating Diseases (Demyelinating Disease) 01/2022 - 06/2002
5	Neuroinflammatory Diseases 01/2020 - 02/2002
5	Amyloid Plaque 03/2017 - 07/2004
5	Chronic Disease (Chronic Diseases) 07/2015 - 06/2002
5	Heart Arrest (Cardiac Arrest) 05/2015 - 07/2006
4	Relapsing-Remitting Multiple Sclerosis 01/2022 - 06/2009
4	Neoplasms (Cancer) 10/2019 - 11/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018 - 04/2010
4	Encephalitis (Encephalitis, Rasmussen) 01/2016 - 03/2005
3	Ischemia 01/2023 - 10/2006
3	Stroke (Strokes) 01/2017 - 04/2007
3	Acidosis 10/2012 - 10/2006
3	Hypertrophy 08/2012 - 03/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2007 - 01/2003
2	Wounds and Injuries (Trauma) 10/2018 - 02/2002
2	Autoimmune Diseases (Autoimmune Disease) 12/2012 - 03/2004
2	Hypoxia (Hypoxemia) 10/2012 - 05/2008
2	Hyperlactatemia 10/2012 - 09/2009
2	Brain Neoplasms (Brain Tumor) 01/2008 - 02/2007
2	Insulin Resistance 01/2007 - 11/2006
1	Neuralgia (Stump Neuralgia) 01/2022
1	Glaucoma 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Alcoholism (Alcohol Abuse) 11/2020
1	Binge Drinking 11/2020

Drug/Important Bio-Agent (IBA)

12	PPAR gammaIBA 10/2009 - 06/2002
11	bromfenacoum (Ratak)IBA 01/2021 - 01/2015
11	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2018 - 04/2002
10	Pioglitazone (Actos)FDA Link 03/2010 - 06/2002
9	Peptides (Polypeptides)IBA 07/2015 - 06/2002
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 07/2004
8	Myelin-Oligodendrocyte GlycoproteinIBA 07/2015 - 06/2002
7	RodenticidesIBA 04/2024 - 01/2018
7	AnticoagulantsIBA 01/2021 - 01/2017
7	LipidsIBA 05/2015 - 05/2003
7	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 02/2014 - 05/2003
6	CytokinesIBA 01/2023 - 06/2002
6	EmulsionsIBA 05/2015 - 05/2003
5	Amyloid beta-PeptidesIBA 10/2013 - 04/2002
4	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 04/2024 - 01/2018
4	EstersIBA 01/2022 - 07/2015
4	lanthionine ketimineIBA 01/2022 - 07/2015
4	Phosphotransferases (Kinase)IBA 10/2021 - 03/2013
4	CannabinoidsIBA 07/2021 - 01/2019
4	Warfarin (Coumadin)FDA LinkGeneric 03/2019 - 01/2015
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 10/2004
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2016 - 04/2007
4	Epinephrine (Adrenaline)FDA LinkGeneric 10/2012 - 05/2008
4	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2008 - 03/2004
3	CoagulantsIBA 04/2024 - 01/2016
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2021 - 01/2015
3	Vitamin K FDA Link 01/2021 - 01/2016
3	difenacoumIBA 06/2020 - 01/2016
3	Neuroprotective AgentsIBA 01/2019 - 06/2009
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2010 - 01/2003
3	Protein Isoforms (Isoforms)IBA 12/2006 - 02/2002
2	Lipocalin-2IBA 10/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 10/2023 - 12/2006
2	Semaphorin-3AIBA 01/2022 - 01/2019
2	bromadioloneIBA 06/2020 - 01/2020
2	VincamineIBA 01/2019 - 04/2012
2	vindeburnolIBA 01/2019 - 04/2012
2	Hemoglobins (Hemoglobin)IBA 01/2017 - 01/2015
2	Local AnestheticsIBA 05/2015 - 09/2009
2	Macrocyclic LactamsIBA 02/2013 - 02/2002
2	Transcription Factors (Transcription Factor)IBA 04/2011 - 04/2007
2	PPAR deltaIBA 10/2009 - 11/2005
2	Isoflurane FDA LinkGeneric 09/2009 - 05/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2008 - 10/2004
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2007 - 11/2006
2	ThiazolidinedionesIBA 01/2007 - 01/2003
2	PPAR-gamma AgonistsIBA 11/2006 - 03/2004
2	LigandsIBA 11/2005 - 06/2002
2	I-kappa B Proteins (I kappa B)IBA 08/2002 - 08/2002
2	NF-kappa B (NF-kB)IBA 08/2002 - 08/2002
1	JNK Mitogen-Activated Protein KinasesIBA 01/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	CalciumIBA 01/2022
1	Voltage-Gated Sodium ChannelsIBA 01/2022
1	lanthionineIBA 01/2022
1	CuprizoneIBA 01/2022
1	Ethanol (Ethyl Alcohol)IBA 11/2020
1	difethialoneIBA 06/2020
1	flocoumafenIBA 06/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 10/2019

Therapy/Procedure

9	Therapeutics 01/2022 - 07/2004
4	Resuscitation 09/2009 - 05/2003
2	Immunotherapy 01/2008 - 02/2007
2	Oral Administration 11/2006 - 03/2004